201 related articles for article (PubMed ID: 26272674)
1. Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology.
Wang LX; Liu K; Lin GW; Jiang T
Cancer Imaging; 2015 Aug; 15(1):13. PubMed ID: 26272674
[TBL] [Abstract][Full Text] [Related]
2. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
3. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
4. Primary hepatic neuroendocrine tumors: clinical characteristics and imaging features on contrast-enhanced ultrasound and computed tomography.
Li R; Tang CL; Yang D; Zhang XH; Cai P; Ma KS; Guo DY; Ding SY
Abdom Radiol (NY); 2016 Sep; 41(9):1767-75. PubMed ID: 27156080
[TBL] [Abstract][Full Text] [Related]
5. Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors: prediction of the histologic grade using pure diffusion coefficient and tumor size.
Hwang EJ; Lee JM; Yoon JH; Kim JH; Han JK; Choi BI; Lee KB; Jang JY; Kim SW; Nickel MD; Kiefer B
Invest Radiol; 2014 Jun; 49(6):396-402. PubMed ID: 24500090
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of primary hepatic neuroendocrine neoplasm and metastatic hepatic neuroendocrine neoplasm: a comparative study.
Sheng R; Xie Y; Zeng M; Ji Y; Rao S; Chen C
Radiol Med; 2015 Nov; 120(11):1012-20. PubMed ID: 25907993
[TBL] [Abstract][Full Text] [Related]
7. Cystic Primary Hepatic Neuroendocrine Tumor.
Kim JM; Lee WA; Shin HD; Song IH; Kim SB
Korean J Gastroenterol; 2021 Nov; 78(5):300-304. PubMed ID: 34824189
[TBL] [Abstract][Full Text] [Related]
8. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization.
Liapi E; Geschwind JF; Vossen JA; Buijs M; Georgiades CS; Bluemke DA; Kamel IR
AJR Am J Roentgenol; 2008 Jan; 190(1):67-73. PubMed ID: 18094295
[TBL] [Abstract][Full Text] [Related]
9. Primary hepatic neuroendocrine carcinoma: MR imaging findings including preliminary observation on diffusion-weighted imaging.
Li RK; Zhao J; Rao SX; Chen CZ; Zeng MS; Qiang JW
Abdom Imaging; 2013 Dec; 38(6):1269-76. PubMed ID: 23942951
[TBL] [Abstract][Full Text] [Related]
10. Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival.
Min JH; Kang TW; Kim YK; Kim SH; Shin KS; Lee JE; Ha SY; Sohn I
Eur Radiol; 2018 Jun; 28(6):2561-2571. PubMed ID: 29368162
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.
Jin F; Wang K; Qin TT; Li X; Guo F; Ma GN; Hu XH; Han P
J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):587-595. PubMed ID: 28786064
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
13. Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
Tsai SD; Kawamoto S; Wolfgang CL; Hruban RH; Fishman EK
Abdom Imaging; 2015 Jun; 40(5):1121-30. PubMed ID: 25504375
[TBL] [Abstract][Full Text] [Related]
14. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma.
Lin J; Ji Y
Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):154-8. PubMed ID: 20382586
[TBL] [Abstract][Full Text] [Related]
15. Case Report of Contrast-Enhanced Ultrasound Features of Primary Hepatic Neuroendocrine Tumor: A CARE-Compliant Article.
Li W; Zhuang BW; Wang Z; Liao B; Hong LY; Xu M; Lin XN; Xie XY; Lu MD; Chen LD; Wang W
Medicine (Baltimore); 2016 May; 95(21):e3450. PubMed ID: 27227910
[TBL] [Abstract][Full Text] [Related]
16. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors.
Jang KM; Kim SH; Lee SJ; Choi D
Acta Radiol; 2014 Mar; 55(2):140-8. PubMed ID: 23897307
[TBL] [Abstract][Full Text] [Related]
17. Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations.
Yang K; Cheng YS; Yang JJ; Jiang X; Guo JX
Cancer Imaging; 2017 Jul; 17(1):20. PubMed ID: 28683830
[TBL] [Abstract][Full Text] [Related]
18. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.
Kim JH; Eun HW; Kim YJ; Han JK; Choi BI
Abdom Imaging; 2013 Oct; 38(5):1106-14. PubMed ID: 23728305
[TBL] [Abstract][Full Text] [Related]
19. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
